Probiotic
Probiotic is a dietary supplement with 328 clinical trials. Currently 53 active trials ongoing. Historical success rate of 96.9%.
Success Metrics
Based on 186 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
50
Mid Stage
22
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.0%
186 of 200 finished
7.0%
14 ended early
53
trials recruiting
328
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Probiotic Improve Constipation
Probiotics for Constipation Relief in Adults
Adults With Constipation
The Gut - PRO Study
EXploratory Study on Postprandial Energy Metabolism
Clinical Trials (328)
Probiotic Improve Constipation
Probiotics for Constipation Relief in Adults
Adults With Constipation
The Gut - PRO Study
EXploratory Study on Postprandial Energy Metabolism
The Bloom Infant Probiotic (BIP) Study
Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer
Oral Lactobacillus Crispatus LCr86 Reduces Nugent Score and Improves Vaginal Microecology in Women With Intermediate Vaginal Microbiota
Effect of a Probiotic or Postbiotic on Gut Microbiome During Antibiotic Treatment
Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease
Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
Effect of a Probiotic on the Female Genital Tract Microbiota of Participants With Fertility Disorders.
Prevention av Autoimmunitet Med Laktobaciller
Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection.
Probiotic for Weight Management in Overweight and Obese Adults
Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study
Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes
An Intervention Study in Healthy Infants Aged 0-6 Months With Probiotics Lacticaseibacillus Rhamnosus LRa05 (LRa05) and Bifidobacterium Animalis Subsp. Lactis BLa80 (BLa80) vs. Placebo, for Promoting Gut Microbiome Development.
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 328